{"result": "(\"entity\"<|>BETHESDA SYSTEM<|>ORGANIZATION<|>The Bethesda System is a classification system for reporting thyroid cytopathology, providing guidelines for the management of thyroid nodules and differentiated thyroid cancer.)\n##\n(\"entity\"<|>AMERICAN THYROID ASSOCIATION<|>ORGANIZATION<|>The American Thyroid Association is a professional organization that provides guidelines for the management of thyroid conditions, including nodules and cancer.)\n##\n(\"entity\"<|>BONGIOVANNI ET AL.<|>PERSON<|>Bongiovanni et al. conducted a meta-analysis on the Bethesda System for Reporting Thyroid Cytopathology, contributing to the understanding of malignancy risks in thyroid nodules.)\n##\n(\"entity\"<|>CIBAS ET AL.<|>PERSON<|>Cibas et al. authored a significant paper on the Bethesda System for Reporting Thyroid Cytopathology, detailing its application in clinical practice.)\n##\n(\"entity\"<|>THYROID<|>GEO<|>The thyroid is a gland in the neck that produces hormones regulating metabolism and is often the site of nodules that may require cytological evaluation.)\n##\n(\"entity\"<|>NODULOS TIROIDEOS<|>EVENT<|>Thyroid nodules are abnormal growths in the thyroid gland that may require evaluation through fine-needle aspiration biopsy (PAAF) to assess for malignancy.)\n##\n(\"relationship\"<|>BETHESDA SYSTEM<|>AMERICAN THYROID ASSOCIATION<|>The Bethesda System is endorsed by the American Thyroid Association for the management of thyroid nodules and cancer<|>8)\n##\n(\"relationship\"<|>BONGIOVANNI ET AL.<|>BETHESDA SYSTEM<|>Bongiovanni et al. provided a meta-analysis that supports the Bethesda System's classification of thyroid nodules<|>7)\n##\n(\"relationship\"<|>CIBAS ET AL.<|>BETHESDA SYSTEM<|>Cibas et al. contributed to the development and understanding of the Bethesda System for Reporting Thyroid Cytopathology<|>7)\n##\n(\"relationship\"<|>NODULOS TIROIDEOS<|>BETHESDA SYSTEM<|>The Bethesda System is used to classify and manage thyroid nodules<|>9)\n##\n(\"relationship\"<|>NODULOS TIROIDEOS<|>THYROID<|>Thyroid nodules are located in the thyroid gland and are evaluated for potential malignancy<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ado indeterminado) justifica el tratamiento quirúrgico en todos los casos.\nC. La categoría Bethesda IV (lesión sospechosa de neoplasia folicular) comporta un riesgo del 50-75% para malignidad.\nD. A y C son correctas.\n\nCOMENTARIO\n\nEn caso de una citología inicial no diagnóstica, en el estudio de un nódulo tiroideo se ha demostrado que la repetición de la punción aspirativa con aguja fina (PAAF) con control ecográfico aumenta de forma sustancial la probabilidad de llegar a un diagnóstico citológico del nódulo. Aunque se ha sugerido la conveniencia de esperar 3 meses para repetir la PAAF, estudios más recientes no corroboran la necesidad de este lapso. La indicación de repetir la PAAF en estos casos está recogida en la Guía ATA 2015 para el manejo de los nódulos tiroideos y carcinoma diferenciado de tiroides. Por lo tanto, la opción A correcta.\n\nLa probabilidad de malignidad en la categoría Bethesda III se sitúa entre el 5% y el 15%, por lo que en estos casos se recomienda inicialmente repetir la PAAF y valorar factores clínicos y patrón ecográfico del nódulo. Después, de acuerdo con las preferencias del paciente, se puede optar por la vigilancia o extirpación quirúrgica (opción B falsa).\n\nLa posibilidad de malignidad en la categoría IV de la clasificación Bethesda oscila entre el 15% y el 30%. Concretamente, en el metaanálisis de Bongiovanni et al., la incidencia de malignidad en 1.791 casos de nódulos con citología sospechosa de neoplasia folicular era de 26,1%, muy lejos del 50-75% que figura en la opción C.\n\nReferencias:\n• Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW. The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis. Acta Cytol. 2012;56:333-9.\n• Cibas ES, Ali SZ. The Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol. 2009;132:658-65.\n• Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1-133.\n• Layfield LJ, Abrams J, Cochand-Priollet B, Evans D, Gharib H, Greenspan F, et al. 2008 Post-thyroid FNA testing and treatment options: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Diagn Cytopathol. 2008;36:442-8.\n• Lubitz CC, Nagarkatti SS, Faquin WC, Samir AE, Hassan MC, Barbesino G, et al. Diagnostic yield of nondiagnostic thyroid nodules is not altered by timing of repeat biopsy. Thyroid. 2012; 22:590-4.\n• Orija IB, Pineyro M, Biscotti C, Reddy SS, Hamrahian AH. Value of repeating a nondiagnostic thyroid fine-needle aspiration biopsy. Endocr Pract. 2007;13:735-42.\n• Redman R, Zalaznick H, Mazzaferri EL, Massoll NA. The impact of assessing specimen adequacy and number of needle passes for fine-needle aspiration biopsy of thyroid nodules. Thyroid. 2006;16:55-60.\n• Singh RS, Wang HH. Timing of repeat thyroid fine-needle aspiration in the management of thyroid nodules. Acta Cytol. 2011;55:544.8.\n\n## 32 Según las guías en vigor, la punción aspirativa con aguja fina (PAAF) en nódulos tiroideos está indicada (señale la respuesta falsa):\n\nA. De rutina en nódulos de moderada sospecha, independientemente del tamaño.\nB. Con propósitos evacuadores en quistes simples.\nC. En nódulos que vayan a ser sometidos a terapia ablativa mínimamente invasiva.\nD. En nódulos de alta sospecha con tamaño entre 0,5-1 cm si coexisten adenopatías sospechosas.\n---\nTIROIDES 3\n\n## COMENTARIO\n\nLa primera opción a la pregunta es claramente falsa. En efecto, las guías de la ATA recomiendan la evaluación citológica de los nódulos tiroideos, dependiendo de su tamaño y riesgo ecográfico de malignidad:\n\n• En caso de sospecha elevada o intermedia de malignidad en la ecografía tiroidea se recomienda punción aspirativa con aguja fina (PAAF) de los nódulos mayores o iguales de 1 cm.\n• En caso de sospecha baja, se recomienda realizar PAAF en los nódulos mayores\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}